{"gao_id": "GAO-13-592", "published": "2013-07-08T12:00:00Z", "released": "2013-07-08T08:00:00Z", "summary": "", "title": "Electronic Drug Labeling: No Consensus on the Advantages and Disadvantages of Its Exclusive Use", "topics": ["Government information dissemination", "Internet", "Pharmaceutical industry", "Drugs", "Health Care", "Physicians", "Patient care services", "Pharmacy", "Prescription drugs", "Federal regulations"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-13-592", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-13-592-highlights.pdf"}, {"title": "Full Report (25 pages)", "url": "https://www.gao.gov/assets/gao-13-592.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/660/655785.txt"}]}